Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos One|October 22, 2021
Reproducibility and discrimination of different indices of insulin sensitivity and insulin secretionSarah Hudak, Philipp Huber, Apostolia Lamprinou, et al.
Medical Physics|November 28, 2023
Investigating focal spot position drift in a mobile imaging system equipped with a monobloc-based x-ray generatorIvan Michael Messner, Peter Keuschnigg, Bernhard Stöllinger, et al.
Materials (Basel, Switzerland)|July 19, 2020
Influence of the Infill Orientation on the Properties of Zirconia Parts Produced by Fused Filament FabricationSantiago Cano, Tanja Lube, Philipp Huber, et al.
Physics in Medicine and Biology|April 16, 2020
A Monte Carlo based scatter removal method for non-isocentric cone-beam CT acquisitions using a deep convolutional autoencoderBrent van der Heyden, Martin Uray, Gabriel Paiva Fonseca, et al.
Nature Materials|October 25, 2022
Templated encapsulation of platinum-based catalysts promotes high-temperature stability to 1,100 °CAisulu Aitbekova, Chengshuang Zhou, Michael L Stone, et al.
Inflammatory Bowel Diseases|August 4, 2023
A Gradient of Intestinal Inflammation in Primary Sclerosing CholangitisAgnes Wittek, Babett Steglich, Christian Casar, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 10, 2020
The TUDID Study - Background and Design of a Prospective CohortBenjamin Assad Jaghutriz, Robert Wagner, Stephanie Kullmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2017
A Protective Function of IL-22BP in Ischemia Reperfusion and Acetaminophen-Induced Liver InjuryDörte Kleinschmidt, Anastasios D Giannou, Heather M McGee, et al.
Gastroenterology|June 26, 2020
IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and HumansJan Kempski, Anastasios D Giannou, Kristoffer Riecken, et al.
BJU International|February 16, 2026
Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancerMulham Al-Nader, Claudia Kesch, Osama Mahmoud, et al.
Pageof 2